DE69736326D1 - Il-1/tnf-alpha-activated kinase (itak), und verfahren zu ihrer herstellung und verwendung - Google Patents

Il-1/tnf-alpha-activated kinase (itak), und verfahren zu ihrer herstellung und verwendung

Info

Publication number
DE69736326D1
DE69736326D1 DE69736326T DE69736326T DE69736326D1 DE 69736326 D1 DE69736326 D1 DE 69736326D1 DE 69736326 T DE69736326 T DE 69736326T DE 69736326 T DE69736326 T DE 69736326T DE 69736326 D1 DE69736326 D1 DE 69736326D1
Authority
DE
Germany
Prior art keywords
itak
tnf
alpha
activated kinase
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69736326T
Other languages
English (en)
Other versions
DE69736326T2 (de
Inventor
E Sims
Duke Virca
A Bird
M Anderson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunex Corp
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of DE69736326D1 publication Critical patent/DE69736326D1/de
Application granted granted Critical
Publication of DE69736326T2 publication Critical patent/DE69736326T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
DE69736326T 1996-06-10 1997-06-09 Il-1/tnf-alpha-activated kinase (itak), und verfahren zu ihrer herstellung und verwendung Expired - Fee Related DE69736326T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63341496A 1996-06-10 1996-06-10
US633414 1996-06-10
PCT/US1997/008516 WO1997047750A1 (en) 1996-06-10 1997-06-09 IL-1/TNF-α-ACTIVATED KINASE (ITAK), AND METHODS OF MAKING AND USING THE SAME

Publications (2)

Publication Number Publication Date
DE69736326D1 true DE69736326D1 (de) 2006-08-24
DE69736326T2 DE69736326T2 (de) 2007-07-19

Family

ID=24539544

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69736326T Expired - Fee Related DE69736326T2 (de) 1996-06-10 1997-06-09 Il-1/tnf-alpha-activated kinase (itak), und verfahren zu ihrer herstellung und verwendung

Country Status (14)

Country Link
EP (1) EP0914451B1 (de)
JP (1) JP2000512147A (de)
KR (1) KR20000016286A (de)
AT (1) ATE332974T1 (de)
AU (1) AU718792B2 (de)
CA (1) CA2257373A1 (de)
DE (1) DE69736326T2 (de)
DK (1) DK0914451T3 (de)
ES (1) ES2270463T3 (de)
IL (1) IL127363A (de)
NO (1) NO985742L (de)
NZ (1) NZ333214A (de)
PT (1) PT914451E (de)
WO (1) WO1997047750A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2481100A (en) * 1998-12-18 2000-07-03 Immunex Corporation Methods for regulating vascularization using gef containing nek-like kinase (gnk)
WO2001023402A1 (en) * 1999-09-27 2001-04-05 Human Genome Sciences, Inc. 43 human secreted proteins
WO2000073469A2 (en) * 1999-05-28 2000-12-07 Sugen, Inc. Protein kinases
US6911336B2 (en) 2000-10-18 2005-06-28 Immunex Corporation GNK interacting amino acid decarboxylase and methods of use thereof
AU2003218238A1 (en) * 2002-03-15 2003-09-29 Incyte Corporation Proteins associated with growth, differentiation, and death
US20060052582A1 (en) * 2002-06-11 2006-03-09 Joan Roig Amores Identification of inhibitors of mitosis
US7371364B2 (en) 2003-08-15 2008-05-13 Board Of Regents, The University Of Texas System Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741667A (en) * 1994-05-27 1998-04-21 Genentech, Inc. Tumor necrosis factor receptor-associated factors

Also Published As

Publication number Publication date
EP0914451B1 (de) 2006-07-12
DK0914451T3 (da) 2006-11-13
WO1997047750A1 (en) 1997-12-18
NO985742D0 (no) 1998-12-08
IL127363A0 (en) 1999-10-28
NZ333214A (en) 2000-02-28
JP2000512147A (ja) 2000-09-19
EP0914451A1 (de) 1999-05-12
KR20000016286A (ko) 2000-03-25
AU3284297A (en) 1998-01-07
IL127363A (en) 2007-05-15
PT914451E (pt) 2006-12-29
ES2270463T3 (es) 2007-04-01
AU718792B2 (en) 2000-04-20
NO985742L (no) 1999-02-10
ATE332974T1 (de) 2006-08-15
DE69736326T2 (de) 2007-07-19
CA2257373A1 (en) 1997-12-18

Similar Documents

Publication Publication Date Title
ATE449850T1 (de) Mutanten von flt3-l und ihre verwendungen
ATA312987A (de) Brenzkatechin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneistoffe
DE68929043T2 (de) Für androgen-rezeptor-protein kodierende dna
ATE219380T1 (de) Vehikel zum einbringen von nukleinsäuren in zellen
DE3878326T3 (de) Kunstlunge der Membranart und Verfahren zu ihrer Verwendung.
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
DE69939327D1 (de) Funktionelle antagonisten von hedgehog-aktivität
ATE32728T1 (de) Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel.
HUP0001937A2 (hu) Új vegyületek, eljárás előállításukra és alkalmazásuk nukleinsavak sejtekbe való bevitelére
PT907731E (pt) Receptores gaba[b] metabotropicos, ligandos especificos dos receptores e suas utilizacoes
ATE266030T1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
DE69736326D1 (de) Il-1/tnf-alpha-activated kinase (itak), und verfahren zu ihrer herstellung und verwendung
AU6745287A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
DE69637154D1 (de) Hocheffizientes gewebespezifisches system zur bereitstellung von verbindungen unter verwendung eines streptavidin-protein a fusionsproteins
DE3789569D1 (de) Zementzusammensetzung und Verfahren zu ihrer Herstellung.
DE68926025D1 (de) Methode zur Herstellung von alpha-Amylase hemmenden Substanzen aus Weizen
DE69705967D1 (de) Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung
SE9602822D0 (sv) New receptor
DE3855634T2 (de) Innerhalb des alpha-Locus gelegenes T-Zell-Rezeptor-Gen und DNA-Konstruktionen
AR022150A1 (es) Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados
DE3673734D1 (de) Xanthinderivate, verfahren zu ihrer herstellung und ihre verwendung als medikamente.
DE3682370D1 (de) 3-aminocarbonyl-1,4-dihydropyridin-5-carboxylsaeurederivate, verfahren zu ihrer herstellung, ihre verwendung und diese enthaltende pharmazeutische zusammensetzungen.
DE3886912T2 (de) Zement enthaltende keramische Gegenstände und Verfahren zu ihrer Herstellung.
Compton et al. Cell cycle withdrawal without concomitant differentiation: analysis of a G1-specific temperature-sensitive murine myoblast cell line
Germenis et al. C3 polymorphism in Greece

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOCKHORNI & KOLLEGEN, 80687 MUENCHEN

8339 Ceased/non-payment of the annual fee